OHNISHI NEUROLOGICAL CENTRE
Ohnishi Neurological Centre provides 24 hours a day medical care for neurological disorders.
OHNISHI NEUROLOGICAL CENTRE
Industry:
Health Care Hospital Medical Neuroscience
Founded:
2000-12-01
Address:
Akashi, Hyogo, Japan
Country:
Japan
Website Url:
http://www.onc.akashi.hyogo.jp
Total Employee:
251+
Status:
Active
Contact:
078-938-1238
Technology used in webpage:
Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Euro US Privacy User Signal Mechanism AJAX Libraries API PHP COVID-19
Similar Organizations
Mable (Neurolytic Healthcare)
Genomics based individualized care for people with neurological conditions.
Texas Institute For Neurological Disorders
Texas Institute for Neurological Disorders provides collaborative, comprehensive, and convenient neurology care for patients.
Official Site Inspections
http://www.onc.akashi.hyogo.jp Semrush global rank: 2.35 M Semrush visits lastest month: 7.89 K
- Host name: 194.91.7.114
- IP address: 194.91.7.114
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Ohnishi Neurological Centre"
TOP | 大西脳神経外科病院
Oct 31, 2024 医療法人社団英明会 大西脳神経外科病院 〒674-0064 兵庫県明石市大久保町江井島1661-1 tel 078-938-1238 fax 078-938-1236See details»
脳梗塞 - 大西脳神経外科病院
医療法人社団英明会 大西脳神経外科病院 〒674-0064 兵庫県明石市大久保町江井島1661-1 tel 078-938-1238 fax 078-938-1236See details»
2023 Japan Society of clinical oncology clinical practice guidelines ...
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis ... Hyogo Cancer Center, 13-70 Kitaoji-Cho, Akashi, Hyogo, 673-0021, Japan. 22 Non-Profit …See details»
Clinical benefits of adding olanzapine to 5-HT3 receptor ... - PubMed
Nov 21, 2024 23 Division of Medical Oncology, Hyogo Cancer Center, 13‑70 Kitaoji‑Cho, Akashi, Hyogo, 673‑0021, Japan. 24 Non-Profit Organization Ehime Cancer Support Orange …See details»
Hyogo Cancer Center | Akashi, Japan - ResearchGate
Similarly, using data from the gynecological cancer registry of the Japan Society of Obstetrics and Gynecology, the annual number of ICCs among women aged 20-29 years also decreased …See details»
Clinical questions and good practice statements of clinical practice ...
20 Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan. 21 Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Japan. 22 …See details»
A phase II study to evaluate abscopal effect by palliative radiation ...
2 Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan. 3 Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, ... 10 …See details»
Ohnishi Neurological Centre - Crunchbase Company Profile
Ohnishi Neurological Centre is located in Akashi, Hyogo, Japan. Who are Ohnishi Neurological Centre 's competitors? Alternatives and possible competitors to Ohnishi Neurological Centre …See details»
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due …
Immune checkpoint inhibitors (ICIs) have emerged as promising therapeutic agents in non-small cell lung cancer (NSCLC). However, the duration for which ICIs should be continued remains a …See details»
Ōnishi nō keisei geka - Overview, News & Competitors - ZoomInfo
Hospitals & Physicians Clinics · Japan · 66 Employees. Ōnishi nō keisei geka is a company that operates in the Hospital & Health Care industry. It employs 51-100 people and has $10M …See details»
Evaluating the Self-Care Agency of Patients Receiving Outpatient ...
University of Hyogo in Akashi, Hyogo, Japan; Harue Arao, PhD, RN, is a professor in the Graduate School of Medicine and Tamami Kobayashi, ... MN, OCNS, RN, is an oncology …See details»
Efficacy, safety, and biomarker analysis of nivolumab in ... - PubMed
10 Department of Surgical Oncology, Graduate School of Medicine, Gifu University, Gifu, Japan. 11 Department of Medical Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan. 12 …See details»
Phase II Study of Etoposide and Cisplatin With Concurrent Twice …
Nov 20, 2006 From the Department of Respiratory Medicine, Aichi Cancer Center Aichi Hospital, Okazaki, Aichi; Departments of Thoracic Oncology and Respiratory Medicine, Hyogo Medical …See details»
Primary resistance to nivolumab plus ipilimumab therapy affects …
1 day ago Nivolumab plus ipilimumab (NIVO+IPI) has a long-term response rate of 30% for patients with metastatic renal cell carcinoma (mRCC). However, 20% of patients develop …See details»
uketaiiryou2025a - onc.akashi.hyogo.jp
Https://www.onc.akashi.hyogo.jp D 3:11 7 24 0 fflJ & D a) | 24 1983f*RlÆïåAft M 2 o 1 6 5 U s 1 Îdij '-7674-0064 7671-1227 TEL 079-272-8555 https:(/www.tsukazaki-hp.jp TEL 078-938-1238 …See details»
Assessment of Outcomes From 1-Year Surveillance After ... - PubMed
Aug 1, 2022 Assessment of Outcomes From 1-Year Surveillance After Detection of Early Gastric Cancer Among Patients at High Risk in Japan JAMA Netw Open. 2022 Aug 1 ... 1 Department …See details»
4-Hydroxyl-2-Nonenal Localized Expression Pattern in Retrieved
Affiliations 1 Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kita-ku, Okayama 700 …See details»
Visiting Japan in December - the Best Things to Do and ... - LIVE …
1 day ago Surprisingly, December is among the more popular seasons to visit Japan. In fact, according to Japan National Tourism Organization data on international visitors, in recent …See details»
uketaiiryou2025d - onc.akashi.hyogo.jp
Https://www.onc.akashi.hyogo.jp 10 L .ï674-0064 TEL078-938-1238See details»
Real-world clinical outcomes and prognostic factors in Japanese ...
Background: The aims of this study are to evaluate the efficacy and safety of first-line treatment with chemotherapy plus cetuximab in real-world patients with recurrent or metastatic …See details»